J F Cade Selected Research

Heparin (Liquaemin)

11/2001

Prospective randomised open-label comparison of danaparoid with dextran 70 in the treatment of heparin-induced thrombocytopaenia with thrombosis: a clinical outcome study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J F Cade Research Topics

Disease

1	Infections 04/2003
1	Peptic Ulcer (Peptic Ulcers) 04/2003
1	Embolism (Embolus) 11/2001
1	Hemorrhage 11/2001
1	Thrombosis (Thrombus) 11/2001
1	Septic Shock (Toxic Shock Syndrome) 07/2000
1	Sepsis (Septicemia) 07/2000
1	Critical Illness (Critically Ill) 07/2000
1	Shock 07/2000

Drug/Important Bio-Agent (IBA)

1	Blood Group Antigens (Blood Groups)IBA 04/2003
1	ABO Blood-Group SystemIBA 04/2003
1	Heparin (Liquaemin)FDA LinkGeneric 11/2001
1	Heparinoids (Heparinoid)IBA 11/2001
1	danaparoid (Orgaran)FDA Link 11/2001
1	Dextrans (Dextran)FDA Link 11/2001
1	Warfarin (Coumadin)FDA LinkGeneric 11/2001
1	Leukemia Inhibitory FactorIBA 07/2000
1	Interleukin-6 (Interleukin 6)IBA 07/2000
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 07/2000
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 07/2000
1	InterleukinsIBA 07/2000